In a filing, Vera Therapeutics Inc revealed its PRESIDENT AND CEO Fordyce Marshall unloaded Company’s shares for reported $1.52 million on Nov 13 ’24. In the deal valued at $49.50 per share,30,625 shares were sold. As a result of this transaction, Fordyce Marshall now holds 85,942 shares worth roughly $4.15 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, MARSHALL FORDYCE bought 30,625 shares, generating $1,486,538 in total proceeds.
Before that, SEIDENBERG BETH C sold 15,000 shares. Vera Therapeutics Inc shares valued at $720,493 were divested by the Director at a price of $48.03 per share. As a result of the transaction, SEIDENBERG BETH C now holds 131,553 shares, worth roughly $6.36 million.
Wells Fargo initiated its Vera Therapeutics Inc [VERA] rating to an Overweight in a research note published on November 21, 2024; the price target was $70. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in mid October with a ‘”a Sector outperform”‘ rating. Oppenheimer began covering VERA with “an Outperform” recommendation on January 25, 2024. Cantor Fitzgerald started covering the stock on January 08, 2024. It rated VERA as “an Overweight”.
Price Performance Review of VERA
On Friday, Vera Therapeutics Inc [NASDAQ:VERA] saw its stock jump 2.72% to $48.31. Over the last five days, the stock has gained 4.43%. Vera Therapeutics Inc shares have risen nearly 214.11% since the year began. Nevertheless, the stocks have risen 267.10% over the past one year. While a 52-week high of $51.61 was reached on 11/13/24, a 52-week low of $12.28 was recorded on 01/19/24. SMA at 50 days reached $43.47, while 200 days put it at $40.72.
Levels Of Support And Resistance For VERA Stock
The 24-hour chart illustrates a support level at 47.29, which if violated will result in even more drops to 46.28. On the upside, there is a resistance level at 49.13. A further resistance level may holdings at 49.96. The Relative Strength Index (RSI) on the 14-day chart is 59.06, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.58, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 40.22%. Stochastics %K at 51.52% indicates the stock is a holding.
How much short interest is there in Vera Therapeutics Inc?
A steep rise in short interest was recorded in Vera Therapeutics Inc stocks on 2024-10-31, growing by 0.22 million shares to a total of 6.39 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 6.17 million shares. There was a rise of 3.43%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 18, 2023 when Raymond James began covering the stock and recommended ‘”an Outperform”‘ rating along with a $29 price target.
